News
ERIS Lifesciences consolidated net profit rises 20.68% in the June 2026 quarter
29-Jul-2026 | 14:25
Sales rise 12.63% to Rs 869.03 crore
Net profit of ERIS Lifesciences rose 20.68% to Rs 142.39 crore in the quarter ended June 2026 as against Rs 117.99 crore during the previous quarter ended June 2025. Sales rose 12.63% to Rs 869.03 crore in the quarter ended June 2026 as against Rs 771.56 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 869.03 | 771.56 | 13 |
| OPM % | 34.04 | 35.86 | - |
| PBDT | 251.56 | 231.61 | 9 |
| PBT | 179.49 | 161.10 | 11 |
| NP | 142.39 | 117.99 | 21 |
Powered by Capital Market - Live News